Cargando…

Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes

BACKGROUND: Methylmalonic acidemia (MMA), a common organic aciduria, is caused by deficiency of the mitochondrial localized, 5'deoxyadenosylcobalamin dependent enzyme, methylmalonyl-CoA mutase (MUT). Liver transplantation in the absence of gross hepatic dysfunction provides supportive therapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandler, Randy J, Tsai, Matthew S, Dorko, Kenneth, Sloan, Jennifer, Korson, Mark, Freeman, Richard, Strom, Stephen, Venditti, Charles P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876207/
https://www.ncbi.nlm.nih.gov/pubmed/17470278
http://dx.doi.org/10.1186/1471-2350-8-24
_version_ 1782133507771858944
author Chandler, Randy J
Tsai, Matthew S
Dorko, Kenneth
Sloan, Jennifer
Korson, Mark
Freeman, Richard
Strom, Stephen
Venditti, Charles P
author_facet Chandler, Randy J
Tsai, Matthew S
Dorko, Kenneth
Sloan, Jennifer
Korson, Mark
Freeman, Richard
Strom, Stephen
Venditti, Charles P
author_sort Chandler, Randy J
collection PubMed
description BACKGROUND: Methylmalonic acidemia (MMA), a common organic aciduria, is caused by deficiency of the mitochondrial localized, 5'deoxyadenosylcobalamin dependent enzyme, methylmalonyl-CoA mutase (MUT). Liver transplantation in the absence of gross hepatic dysfunction provides supportive therapy and metabolic stability in severely affected patients, which invites the concept of using cell and gene delivery as future treatments for this condition. METHODS: To assess the effectiveness of gene delivery to restore the defective metabolism in this disorder, adenoviral correction experiments were performed using murine Mut embryonic fibroblasts and primary human methylmalonyl-CoA mutase deficient hepatocytes derived from a patient who harbored two early truncating mutations, E224X and R228X, in the MUT gene. Enzymatic and expression studies were used to assess the extent of functional correction. RESULTS: Primary hepatocytes, isolated from the native liver after removal subsequent to a combined liver-kidney transplantation procedure, or Mut murine fibroblasts were infected with a second generation recombinant adenoviral vector that expressed the murine methylmalonyl-CoA mutase as well as eGFP from distinct promoters. After transduction, [1-(14)C] propionate macromolecular incorporation studies and Western analysis demonstrated complete correction of the enzymatic defect in both cell types. Viral reconstitution of enzymatic expression in the human methylmalonyl-CoA mutase deficient hepatocytes exceeded that seen in fibroblasts or control hepatocytes. CONCLUSION: These experiments provide proof of principle for viral correction in methylmalonic acidemia and suggest that hepatocyte-directed gene delivery will be an effective therapeutic treatment strategy in both murine models and in human patients. Primary hepatocytes from a liver that was unsuitable for transplantation provided an important resource for these studies.
format Text
id pubmed-1876207
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18762072007-05-22 Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes Chandler, Randy J Tsai, Matthew S Dorko, Kenneth Sloan, Jennifer Korson, Mark Freeman, Richard Strom, Stephen Venditti, Charles P BMC Med Genet Research Article BACKGROUND: Methylmalonic acidemia (MMA), a common organic aciduria, is caused by deficiency of the mitochondrial localized, 5'deoxyadenosylcobalamin dependent enzyme, methylmalonyl-CoA mutase (MUT). Liver transplantation in the absence of gross hepatic dysfunction provides supportive therapy and metabolic stability in severely affected patients, which invites the concept of using cell and gene delivery as future treatments for this condition. METHODS: To assess the effectiveness of gene delivery to restore the defective metabolism in this disorder, adenoviral correction experiments were performed using murine Mut embryonic fibroblasts and primary human methylmalonyl-CoA mutase deficient hepatocytes derived from a patient who harbored two early truncating mutations, E224X and R228X, in the MUT gene. Enzymatic and expression studies were used to assess the extent of functional correction. RESULTS: Primary hepatocytes, isolated from the native liver after removal subsequent to a combined liver-kidney transplantation procedure, or Mut murine fibroblasts were infected with a second generation recombinant adenoviral vector that expressed the murine methylmalonyl-CoA mutase as well as eGFP from distinct promoters. After transduction, [1-(14)C] propionate macromolecular incorporation studies and Western analysis demonstrated complete correction of the enzymatic defect in both cell types. Viral reconstitution of enzymatic expression in the human methylmalonyl-CoA mutase deficient hepatocytes exceeded that seen in fibroblasts or control hepatocytes. CONCLUSION: These experiments provide proof of principle for viral correction in methylmalonic acidemia and suggest that hepatocyte-directed gene delivery will be an effective therapeutic treatment strategy in both murine models and in human patients. Primary hepatocytes from a liver that was unsuitable for transplantation provided an important resource for these studies. BioMed Central 2007-04-30 /pmc/articles/PMC1876207/ /pubmed/17470278 http://dx.doi.org/10.1186/1471-2350-8-24 Text en Copyright © 2007 Chandler et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chandler, Randy J
Tsai, Matthew S
Dorko, Kenneth
Sloan, Jennifer
Korson, Mark
Freeman, Richard
Strom, Stephen
Venditti, Charles P
Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes
title Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes
title_full Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes
title_fullStr Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes
title_full_unstemmed Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes
title_short Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes
title_sort adenoviral-mediated correction of methylmalonyl-coa mutase deficiency in murine fibroblasts and human hepatocytes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876207/
https://www.ncbi.nlm.nih.gov/pubmed/17470278
http://dx.doi.org/10.1186/1471-2350-8-24
work_keys_str_mv AT chandlerrandyj adenoviralmediatedcorrectionofmethylmalonylcoamutasedeficiencyinmurinefibroblastsandhumanhepatocytes
AT tsaimatthews adenoviralmediatedcorrectionofmethylmalonylcoamutasedeficiencyinmurinefibroblastsandhumanhepatocytes
AT dorkokenneth adenoviralmediatedcorrectionofmethylmalonylcoamutasedeficiencyinmurinefibroblastsandhumanhepatocytes
AT sloanjennifer adenoviralmediatedcorrectionofmethylmalonylcoamutasedeficiencyinmurinefibroblastsandhumanhepatocytes
AT korsonmark adenoviralmediatedcorrectionofmethylmalonylcoamutasedeficiencyinmurinefibroblastsandhumanhepatocytes
AT freemanrichard adenoviralmediatedcorrectionofmethylmalonylcoamutasedeficiencyinmurinefibroblastsandhumanhepatocytes
AT stromstephen adenoviralmediatedcorrectionofmethylmalonylcoamutasedeficiencyinmurinefibroblastsandhumanhepatocytes
AT venditticharlesp adenoviralmediatedcorrectionofmethylmalonylcoamutasedeficiencyinmurinefibroblastsandhumanhepatocytes